Trillium Therapeutics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Trillium Therapeutics

An SI Board Since February 2014

Posts	SubjectMarks	Bans	Symbol
294	39	0	TRIL

Emcee: tuck	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
119	The unfortunate folk who bought on this news.... blasted! If you're an e	scaram(o)uche	-	12/13/2017
118	>> really do need a partner << Losing competitive advantage, every	scaram(o)uche	-	12/13/2017
117	The bull case for TRIL (from "Seeking Alpha") Trillium Therapeutics:	Bladerunner17	-	12/12/2017
116	>> Though still good, aren't some other players in the DLBCL space als	scaram(o)uche	-	12/11/2017
115	Trillium has proposed that, once the handcuffs are off, macrophages/monocytes ca	scaram(o)uche	1	12/11/2017
114	Good thoughts. It's been a while since I looked closely at the stuff (like	tuck	-	12/11/2017
113	car-Ts.... significant expense, antigen-negative relapse. ADCs.... relapse	scaram(o)uche	1	12/11/2017
112	Responses down a bit from last update. Though still good, aren't some other	tuck	-	12/11/2017
111	s2.q4cdn.com s2.q4cdn.com Looks good. Looks very good.	scaram(o)uche	-	12/11/2017
110	Well if they can get a clear win in some indication (not just some singles), the	Biomaven	-	12/6/2017
109	Well, they need to increase data-set, so they have more leverage in negotiation!	Miljenko Zuanic	-	12/4/2017
108	Seems clear since Nov. 15th that nothing is in the works for partnering if they	semi_infinite	-	12/4/2017
107	So, here we are.... December. Business Development is concerned with editing	scaram(o)uche	-	12/4/2017
106	My personal hematologist thinks that TTI-2341 is the real gem of the pipeline.	Bladerunner17	-	11/27/2017
105	Nan Guo Ring a Institute for Stem Cell Biology and Regenerative Medicine, and L	scaram(o)uche	-	11/24/2017
104	New paper from Weissman/47; full text might have more info on epitope? Anti-SIR	tuck	-	11/24/2017
103	Poster gives me more clarity on cytokine response than the abstract that only ga	semi_infinite	-	11/12/2017
102	I posted some TRIL SITC observations starting here: twitter.com	Biomaven	-	11/12/2017
101	Found some background data on cytokines for comparison with Tril data released i	semi_infinite	-	11/8/2017
100	To my uneducated eye, the abstracts for ASH look pretty interesting, especially	Bladerunner17	-	11/7/2017
99	Peter had commented in valuation thread that "If you take a stock like Tri	semi_infinite	-	11/7/2017
98	TRIL hits another 52-week high at $10.10. $10 may hold today. Bladerunner	Bladerunner17	-	11/7/2017
97	TRIL hits new 52-week high. ($10) It has pulled back some. Bladerunner	Bladerunner17	-	11/6/2017
96	<At the same time, there is no need for the company to rush business developm	Miljenko Zuanic	-	11/6/2017
95	The bull case for TRIL from "Seeking Alpha" The CD47 Space Is Heating	Bladerunner17	-	11/5/2017

Go to reply# or date (mm/dd/yy):